LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.07% | 983.38% | 128.41% | -634.70% | 109.97% |
| Total Depreciation and Amortization | -0.86% | -0.91% | -3.21% | 1.82% | -6.24% |
| Total Amortization of Deferred Charges | -2.33% | 0.39% | 0.39% | 1.59% | -37.56% |
| Total Other Non-Cash Items | -14.20% | 2.63% | -7.42% | 9.52% | -5.82% |
| Change in Net Operating Assets | -1,225.88% | 110.73% | -178.19% | 146.78% | -300.93% |
| Cash from Operations | -42.48% | 110.94% | -57.63% | 2,182.66% | -104.96% |
| Capital Expenditure | 1.32% | -6.02% | -32.70% | -8.19% | -13.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.50% | -6.02% | -32.70% | -8.19% | -13.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.06% | -0.06% | 0.06% | 99.37% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -74,433.67% | 53.11% | 11.44% | 97.11% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,724.24% | 5.54% | 1.27% | 79.47% | -145.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -220.35% | 198.78% | -72.57% | 369.79% | -138.95% |